Immunohistochemical characterization identified these cells as CD8+, CD4+, CD20+, FOXP3+, CD163+, or CD68+ cells, and the density of each cell type in the tumor-immune microenvironment (TIME) was quantified (Figure S2). The gene discussed is CD8A; the disease is neoplasm.